Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation for Treating Thyroid Nodules Classified as TIR3A, With a Negative Genetic Evaluation for Thyroid Carcinoma

NCT05765695 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT05765695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05765695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation for Treating Thyroid Nodules Classified as TIR3A, With a Negative Genetic Evaluation for Thyroid Carcinoma
Lead sponsor
Istituto Auxologico Italiano
Phase
Not applicable
Overall status
Unknown status
Start date
January 10, 2021
Completion date
January 10, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid nodule